Document is current
Any future updates will be listed below
-
Authors
Wang, Jie
Yau, Chun En https://orcid.org/0000-0002-5844-8962
Low, Chen Ee
Bin Hasan Mohamed, Mohamed Haniffa
Cheng, Chee Leong
Neff, Jadee L. https://orcid.org/0000-0002-4924-4247
Lim, Jing Quan https://orcid.org/0000-0003-3732-8707
Lim, Soon Thye
Chan, Jason Yongsheng https://orcid.org/0000-0002-4801-3703
Ong, Choon Kiat https://orcid.org/0000-0001-6402-4288
Yang, Valerie Shiwen https://orcid.org/0000-0002-8844-9421
-
Funding
Funding for this research was provided by:
MOH | National Medical Research Council (CNIGnov-0025, TA20nov-0020, MOH-OFYIRG22jul-0017, NMRC-OFLCG-18May0028)
SingHealth Duke-NUS Oncology Academic Clinical Programme Khoo Pilot Collaborative Award Terry Fox Grant Khoo Bridge Funding Award
- License Information
-
More Information
Article History
Received: 28 July 2024
Revised: 3 October 2024
Accepted: 8 October 2024
First Online: 26 November 2024
Competing interests
: On behalf of all authors, the corresponding author states that there is no conflict of interest.
: This study conforms to the Declaration of Helsinki. The research study was carried out with approval from the SingHealth Centralised Institutional Review Board (SLS CIRB 2018/3084) and the Duke Institutional Review Board (Pro00105270 Molecular characteristics of T cell malignancies). Informed consent was obtained from all subjects. No identifiable images from human research participants were published in this study.
